Express Pharma

OSCL posts net profit of Rs 8.17 crore in Q1FY16

EBITDA margin reported at Rs 17.26 crore

Omkar Speciality Chemicals Ltd (OSCL) has declared its financial results for the first quarter ended June 30, 2015. The company reported a healthy increase of 64.41 per cent in its net profit to Rs 8.17 crore for Q1FY16, as compared to Rs 4.97 crore in the corresponding quarter of last fiscal.

The total income for the quarter ended June 30, 2015 stood at Rs 90.48 crore, as compared to Rs 53.51 crore in the same period last year. OSCL’s Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q1FY16 stood at Rs 17.26 crore, up 98.02 per cent. The company’s EBITDA margin improved from 16.29 per cent in Q1FY15 to 19.08 per cent in Q1FY16.

Omkar Herlekar, Whole Time Director, OSCL, said, “It is great to start off this fiscal year with a robust increase in our top-line with the commencement of operations of the additional capacity at Chiplun. We believe traction in sales to continue over the coming quarters with a steady improvement in capacity utilization. The margins have increased because of higher composition of speciality chemicals and APIs in the total sales.”

Comments are closed.